Table 2 Clinical details of the control group
Total study group | No comorbidity | Comorbidity 1 disease | Comorbidity >1 disease | |||||
|---|---|---|---|---|---|---|---|---|
(n = 6093) | Range | (n = 4386) | Range | (n = 1411) | Range | (n = 296) | Range | |
No of men/women (%) | 2,822/3,271 (46.3) | 2,067/2,319 (47.1) | 630/781 (44.6) | 125/171 (42.2) | ||||
Mean (SD) age | 52.5 (15.1) | 46.4 (15.1) | 44.7 (15.0) | 20–74 | 49.8 (14.7) | 20–74 | 54.7 (13.1) | 20–74 |
Disease (%) | ||||||||
Cancer | 32 (0.5) | |||||||
Diabetes | 95 (1.6) | |||||||
Cardiovascular | 810 (13.3) | |||||||
Gastrointestinal | 306 (5.0) | |||||||
Miscellaneous | 1,968 (32.3) | |||||||
No. of diseases (%) | ||||||||
0 | 4,386 (72.0) | |||||||
1 | 1,411 (23.2) | |||||||
>1 | 296 (4.9) |